510(k) K191085
K191085 is an FDA 510(k) premarket notification submitted by Genalyte, Inc. for the device "Maverick RNP Assay and Maverick Diagnostic System". The FDA issued a decision of Substantially Equivalent on October 25, 2019. The device falls under product code LKO (Anti-Rnp Antibody, Antigen And Control), a Class II device regulated under 21 CFR 866.5100. Genalyte, Inc. has at least 1 other 510(k) clearance on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 25, 2019
- Date Received
- April 24, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Anti-Rnp Antibody, Antigen And Control
- Device Class
- Class II
- Regulation Number
- 866.5100
- Review Panel
- IM
- Submission Type